This company listing is no longer active
Paragon 28 (FNA) Stock Overview
Develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
FNA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Paragon 28, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$13.09 |
| 52 Week High | US$13.13 |
| 52 Week Low | US$4.65 |
| Beta | 1.47 |
| 1 Month Change | 0.61% |
| 3 Month Change | 15.33% |
| 1 Year Change | 33.71% |
| 3 Year Change | -31.07% |
| 5 Year Change | n/a |
| Change since IPO | -30.04% |
Recent News & Updates
Thirteen New Products Will Expand Global Market Presence
Paragon 28's innovative products and international market penetration are expected to drive sustainable revenue growth and diversification.Fewer Investors Than Expected Jumping On Paragon 28, Inc. (NYSE:FNA)
Jan 27
Recent updates
Thirteen New Products Will Expand Global Market Presence
Paragon 28's innovative products and international market penetration are expected to drive sustainable revenue growth and diversification.Fewer Investors Than Expected Jumping On Paragon 28, Inc. (NYSE:FNA)
Jan 27Is Paragon 28 (NYSE:FNA) Using Too Much Debt?
Dec 23Analysts Have Made A Financial Statement On Paragon 28, Inc.'s (NYSE:FNA) Third-Quarter Report
Nov 15It's Down 28% But Paragon 28, Inc. (NYSE:FNA) Could Be Riskier Than It Looks
Oct 03We Think Paragon 28 (NYSE:FNA) Has A Fair Chunk Of Debt
Sep 18Investors Give Paragon 28, Inc. (NYSE:FNA) Shares A 27% Hiding
Jun 24Is Paragon 28 (NYSE:FNA) Using Too Much Debt?
Jun 07Many Still Looking Away From Paragon 28, Inc. (NYSE:FNA)
Apr 17Paragon 28, Inc. (NYSE:FNA) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 03After Leaping 29% Paragon 28, Inc. (NYSE:FNA) Shares Are Not Flying Under The Radar
Nov 28Paragon 28 announces public offering of 6.5M shares
Jan 25Paragon 28 guides Q4 and FY22 revenue outlook above consensus
Jan 10Paragon 28 GAAP EPS of -$0.13 misses by $0.01, revenue of $46M beats by $3.52M
Nov 10Shareholder Returns
| FNA | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.8% | -0.7% | -1.6% |
| 1Y | 33.7% | -1.4% | 14.4% |
Return vs Industry: FNA exceeded the US Medical Equipment industry which returned 4.5% over the past year.
Return vs Market: FNA exceeded the US Market which returned 5.9% over the past year.
Price Volatility
| FNA volatility | |
|---|---|
| FNA Average Weekly Movement | 2.7% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FNA has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: FNA's weekly volatility has decreased from 10% to 3% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 525 | Albert DaCosta | paragon28.com |
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. The company offers forefoot systems, including gorilla precision MTP plating system, gorilla precision lapidus plating system, phantom lapidus intramedullary nail system, Bun-Yo-Matic lapidus clamp, and precision MIS screw system; and fracture fixation systems comprising gorilla ankle fracture plating system, baby gorilla plating system, monster screw system, monkey bars external fixation system, R3Flex syndesmotic repair system, and phantom fibula nail system. It also provides flatfoot systems, such as gorilla universal plating system, JAWS great white staple system, monster screw system, grappler suture anchor system, and mister tendon harvester system; ankle replacement system consists of metallic and plastic implant components, as well as ankle fusion plating system and phantom hindfoot nailing system; Charcot systems, including the joust beaming system, gorilla medial column plating system, and monkey rings external fixation system; and orthobiologics products, such as V92 cellular bone matrix, PRESERVE bone wedges, MgNum bone void filler, and BEAST demineralized bone matrix.
Paragon 28, Inc. Fundamentals Summary
| FNA fundamental statistics | |
|---|---|
| Market cap | US$1.10b |
| Earnings (TTM) | -US$54.64m |
| Revenue (TTM) | US$256.18m |
Is FNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FNA income statement (TTM) | |
|---|---|
| Revenue | US$256.18m |
| Cost of Revenue | US$64.69m |
| Gross Profit | US$191.49m |
| Other Expenses | US$246.13m |
| Earnings | -US$54.64m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.65 |
| Gross Margin | 74.75% |
| Net Profit Margin | -21.33% |
| Debt/Equity Ratio | 84.8% |
How did FNA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/21 04:11 |
| End of Day Share Price | 2025/04/17 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Paragon 28, Inc. is covered by 3 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Neil Chatterji | B. Riley Securities, Inc. |
| David Turkaly | Citizens JMP Securities, LLC |
| Michael Matson | Needham & Company |